Systematic Review of Diagnostic Accuracy of Fluorodeoxyglucose Positron Emission Tomography for Alzheimer’s Disease

참고문헌 (49)

1. Patwardhan MB, "Alzheimer disease: operating characteristics of PET--a meta-analysis", Radiology, 231, pp.73~80 (2004)
2. Meguro K, "Donepezil and life expectancy in Alzheimer’s disease: a retrospective analysis in the Tajiri Project", BMC Neurol, 14, pp.83~ (2014)
3. Hager K, "Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease", Neuropsychiatr Dis Treat, 10, pp.391~401 (2014)
4. Butler CR, "Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design", J Med Chem, 58, pp.2678~2702 (2015)
5. Barnett JH, "Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing", BMC Neurol, 14, pp.101~ (2014)
6. Moynihan R, "Preventing overdiagnosis: how to stop harming the healthy", BMJ, 344, pp.e3502~ (2012)
7. Jørgensen KJ, "Mammography screening. Benefits, harms, and informed choice", Dan Med J, 60, pp.B4614~ (2013)
8. Marcus PM, "Conceptualizing overdiagnosis in cancer screening", J Natl Cancer Inst, 107, pp.djv014~ (2015)
9. Knottnerus JA, "Evaluation of diagnostic procedures", BMJ, 324, pp.477~480 (2002)
10. Bloudek LM, "Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease", J Alzheimers Dis, 26, pp.627~645 (2011)
11. Petersen RC, "Current concepts in mild cognitive impairment", Arch Neurol, 58, pp.1985~1992 (2001)
12. Rasquin SM, "Predictive accuracy of MCI subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study", Dement Geriatr Cogn Disord, 19, pp.113~119 (2005)
13. Lin JS, "Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force", Ann Intern Med, 159, pp.601~612 (2013)
14. Petersen RC, "Mild cognitive impairment: clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
15. Scheurich A, "Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic", Dement Geriatr Cogn Disord, 20, pp.271~277 (2005)
16. Chételat G, "Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?", Neurology, 60, pp.1374~1377 (2003)
17. Knottnerus JA, "Assessment of the accuracy of diagnostic tests: the cross-sectional study", J Clin Epidemiol, 56, pp.1118~1128 (2003)
18. Whiting PF, "QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies", Ann Intern Med, 155, pp.529~536 (2011)
19. Reitsma JB, "Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews", J Clin Epidemiol, 58, pp.982~990 (2005)
20. Anchisi D, "Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease", Arch Neurol, 62, pp.1728~1733 (2005)
21. Döbert N, "Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index", Dement Geriatr Cogn Disord, 20, pp.63~70 (2005)
22. Drzezga A, "Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET", J Nucl Med, 46, pp.1625~1632 (2005)
23. Fellgiebel A, "FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment", Psychiatry Res, 155, pp.167~171 (2007)
24. Kakimoto A, "New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method", PLoS One, 6, pp.e25033~ (2011)
25. Nobili F, "Principal component analysis of FDG PET in amnestic MCI", Eur J Nucl Med Mol Imaging, 35, pp.2191~2202 (2008)
26. Buschert VC, "Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment", J Clin Psychiatry, 73, pp.e1492~e1498 (2012)
27. 황혜란, "The Effect of Cognitive Training in Patients with Mild Cognitive Impairment and Early Alzheimer’s Disease: A Preliminary Study", Journal of Clinical Neurology, 8(3), pp.190~197 (2012), 대한신경과학회[DOI]
28. Zhang S, "Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer’s disease in subjects with mild cognitive impairment", Int J Clin Pract, 66, pp.185~198 (2012)
29. Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of alzheimer’s disease and dementia, "Matchar DB", Agency for Healthcare Research and Quality, ~, pp.Contract No. 290-97-0014 (2001)
30. Positron emission tomography, single photon emission computed tomography, computed tomography, functional magnetic resonance imaging, and magnetic resonance spectroscopy and for the diagnosis and management of alzheimer’s dementia, "Matchar DB", Agency for Healthcare Research and Quality, ~ (2004)
31. Allegri RF, "Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer’s disease", Vertex, 23, pp.5~15 (2012)
32. Davison CM, "A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review", Int J Geriatr Psychiatry, 29, pp.551~561 (2014)
33. Schmand B, "Value of diagnostic tests to predict conversion to Alzheimer’s disease in young and old patients with amnestic mild cognitive impairment", J Alzheimers Dis, 29, pp.641~648 (2012)
34. Luck T, "Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: results of the Leipzig Longitudinal Study of the Aged", Psychol Med, 41, pp.1087~1097 (2011)
35. Silverman DH, "Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome", JAMA, 286, pp.2120~2127 (2001)
36. Leeflang MM, "Systematic reviews of diagnostic test accuracy", Ann Intern Med, 149, pp.889~897 (2008)
37. Frisoni GB, "Markers of Alzheimer’s disease in a population attending a memory clinic", Alzheimers Dement, 5, pp.307~317 (2009)
38. Yakushev I, "Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer’s disease", Dement Geriatr Cogn Disord, 30, pp.245~253 (2010)
39. Patterson JC, "Early Detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans", Int J Alzheimers Dis, 2011, pp.946590~ (2010)
40. Mosconi L, "Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis", Neurology, 64, pp.1860~1867 (2005)
41. Alexopoulos P, "Progression to dementia in clinical subtypes of mild cognitive impairment", Dement Geriatr Cogn Disord, 22, pp.27~34 (2006)
42. Laforce R Jr, "The value of PET in mild cognitive impairment, typical and atypical", unclear dementias: a retrospective memory clinic study, 2010, pp.25, 324~332
43. Ossenkoppele R, "Impact of molecular imaging on the diagnostic process in a memory clinic", Alzheimers Dement, 9, pp.414~421 (2013)
44. Li Y, "Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease", Eur J Nucl Med Mol Imaging, 35, pp.2169~2181 (2008)
45. Ishii H, "Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer’s disease in a community: the Osaki-Tajiri Project", Int Psychogeriatr, 21, pp.148~156 (2009)
46. Young J, "Accurate multimodal probabilistic prediction of conversion to Alzheimer’s disease in patients with mild cognitive impairment", Neuroimage Clin, 2, pp.735~745 (2013)
47. Galluzzi S, "The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment", J Neurol, 257, pp.2004~2014 (2010)
48. Hatashita S, "Diagnosed mild cognitive impairment due to Alzheimer’s disease with PET biomarkers of beta amyloid and neuronal dysfunction", PLoS One, 8, pp.e66877~ (2013)
49. Arnáiz E, "Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment", Neuroreport, 12, pp.851~855 (2001)

관련 논문AI추천